The oncogenic mechanisms of the PTEN/phosphoinositol-3-kinase signaling pathway, RAC1, CDKN2A, telomerase reverse transcriptase promoter mutations, and several molecular alterations specific to mucosal and chronically sun-damaged melanomas have also been implicated in disease progression [9]. The gene discussed is CDKN2A; the disease is melanoma.